Studies for Parkinson's Disease patients with Dyskinesia

A Pilot Study of Oxaloacetate in Subjects With Treated PD

Purpose: The purpose of this study is to determine if Oxaloacetate (OAA) is a safe and effective treatment for Parkinson's disease.

Duration: 4 months

Study Design: Randomized, double-blind, placebo controlled

Inclusion Criteria:
Both genders ≥ 30 years and older
Diagnosis of idiopathic PD within 7 years of diagnosis
Taking stable doses of levodopa and would not predictably need adjustment in PD medications for 4 months

Exclusion Criteria:
Previously taken Oxaloacetate
Participation in other drug studies or use of other investigational products within 30 days prior to baseline
In the Investigator's opinion, any unstable or clinically significant condition that would impair the subjects' ability to comply with study follow-up
Other known or suspected cause of parkinsonism